Cargando…

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases

Adjuvant endocrine therapy is an integral component of care for endocrine-dependent breast cancer. The aim of this type of therapy is to counteract the production and the action of estrogens. The ovary is the primary site of estrogen production in premenopausal women, whereas, in postmenopausal wome...

Descripción completa

Detalles Bibliográficos
Autores principales:	MADEDDU, CLELIA, GRAMIGNANO, GIULIA, KOTSONIS, PARASKEVAS, PARIBELLO, FRANCESCO, MACCIÒ, ANTONIO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114603/ https://www.ncbi.nlm.nih.gov/pubmed/25120706 http://dx.doi.org/10.3892/ol.2014.2319

Ejemplares similares

Large twisted ovarian fibroma associated with Meigs’ syndrome, abdominal pain and severe anemia treated by laparoscopic surgery
por: Macciò, Antonio, et al.
Publicado: (2014)

Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women
por: Yamazaki, Rena, et al.
Publicado: (2015)

Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients
por: Macciò, Antonio, et al.
Publicado: (2020)

Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer
por: Madeddu, Clelia, et al.
Publicado: (2014)

Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer
por: Sanna, Elisabetta, et al.
Publicado: (2021)

Feasibility and safety of total laparoscopic hysterectomy for huge uteri without the use of uterine manipulator: description of emblematic cases
por: Macciò, Antonio, et al.
Publicado: (2018)

Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report
por: Macciò, Antonio, et al.
Publicado: (2017)

Abdominal leiomyosarcomatosis after surgery with external morcellation for occult smooth muscle tumors of uncertain malignant potential: A case report
por: Macciò, Antonio, et al.
Publicado: (2017)

An interdisciplinary approach for laparoscopic removal of a large retroperitoneal pelvic schwannoma attached to vital vessels: A case report
por: Macciò, Antonio, et al.
Publicado: (2019)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
por: Madeddu, Clelia, et al.
Publicado: (2018)

Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer
por: Madeddu, Clelia, et al.
Publicado: (2019)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study
por: Yamazaki, Rena, et al.
Publicado: (2020)

Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms
por: Madeddu, Clelia, et al.
Publicado: (2022)

Correspondence on “Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer” by Polen-De et al
por: Maccio, Antonio, et al.
Publicado: (2022)

Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials
por: Yan, Shunchao, et al.
Publicado: (2015)

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
por: Buono, Giuseppe, et al.
Publicado: (2022)

Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case–control study
por: Swerdlow, A J, et al.
Publicado: (2007)

COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
por: Macciò, Antonio, et al.
Publicado: (2021)

Effect of Tamoxifen and Raloxifene on the Proliferative Activity of the Breast Epithelium in Premenopausal Women
por: Lucato, Miliana T, et al.
Publicado: (2015)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)

Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
por: Kojima, Nobue, et al.
Publicado: (2018)

Obesity, Inflammation, and Postmenopausal Breast Cancer: Therapeutic Implications
por: Macciò, Antonio, et al.
Publicado: (2011)

Management of Anemia of Inflammation in the Elderly
por: Macciò, Antonio, et al.
Publicado: (2012)

Molecular Basis and Advances in Targeted Immunotherapy for Cancer
por: Macciò, Antonio, et al.
Publicado: (2023)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Laparoscopic management of a giant mucinous benign ovarian mass weighing 10150 grams: A case report
por: Sanna, Elisabetta, et al.
Publicado: (2020)

Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women
por: Eriksson, Mikael, et al.
Publicado: (2021)

Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
por: Pala, Şehmus, et al.
Publicado: (2015)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

A case report of spontaneous ovarian hyperstimulation syndrome and the long-term management of the endocrine disorder
por: Liang, Xuefei, et al.
Publicado: (2022)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique
por: Macciò, Antonio, et al.
Publicado: (2021)

Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome
por: Mantovani, Giovanni, et al.
Publicado: (2013)

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
por: Pagani, Olivia, et al.
Publicado: (2020)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Ovarian reserve in premenopausal women with breast cancer
por: Zong, Xiangyun, et al.
Publicado: (2022)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jv2600kappkfcjkdsq9rcb2cbk